Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America

BACKGROUND: Risperidone long-acting injection (RLAI) has been shown to be efficacious, improve compliance, and increase long-term retention rate on therapy. The aim of this work was to determine the effect of RLAI on clinical outcome and hospitalization rate in patients with schizophrenia or schizoa...

Descripción completa

Detalles Bibliográficos
Autores principales: Apiquian, Rogelio, Córdoba, Rodrigo, Louzã, Mario
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035598/
https://www.ncbi.nlm.nih.gov/pubmed/21326651
http://dx.doi.org/10.2147/NDT.S15911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035598/
https://www.ncbi.nlm.nih.gov/pubmed/21326651
http://dx.doi.org/10.2147/NDT.S15911

Ejemplares similares